The relationship between dynamic change in albumin between pre-treatment and 12 weeks and overall survival in patients with NSCLC treated with first-line targeted therapy or immunotherapy-based therapy: univariate log-rank analysis. The gene discussed is ALB; the disease is non-small cell lung carcinoma.